Human tear lipocalin muteins which specifically bind lymphocyte activation gene-3 (LAG3) and method of use thereof to stimulate an immune response
US-10927156-B2 · Feb 23, 2021 · US
This page is not indexed by search engines while we improve data quality.
Patent family 53719645
This patent family groups 4 related publications across US. Members often share priority claims or equivalent filings in different countries.
| Field | Value |
|---|---|
| Family ID | 53719645 |
| Family type | — |
| Earliest priority | Jul 15, 2015 |
| First filing country | US |
| Member publications | 4 |
| Countries | US |
| Representative publication | US10927156B2 — Human tear lipocalin muteins which specifically bind lymphocyte activation gene-3 (LAG3) and method of use thereof to stimulate an immune response |
Representative publication
Best representative member for this family based on priority and filing country.
US10927156B2 — Human tear lipocalin muteins which specifically bind lymphocyte activation gene-3 (LAG3) and method of use thereof to stimulate an immune response (published Feb 23, 2021)
Member publications
Related publications in this family.
Novel proteins specific for lag-3
US-2020048317-A1 · Feb 13, 2020 · US
Muteins of human tear lipocalin capable of binding lymphocyte-activation gene 3 (LAG-3) and methods of use thereof
US-10501510-B2 · Dec 10, 2019 · US
Novel proteins specific for lag-3
US-2019031729-A1 · Jan 31, 2019 · US